Imaging genomics

British Medical Bulletin

Volumn 65, Issue , 2003, Pages 259-270

  Hariri, Ahmad R ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CATECHOL METHYLTRANSFERASE; SEROTONIN TRANSPORTER;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANXIETY DISORDER; BRAIN REGION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAM; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN GENOME; IMAGING; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEINS E; BRAIN; BRAIN DISEASES; CARRIER PROTEINS; CATECHOL O-METHYLTRANSFERASE; GENOMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0037247423     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/65.1.259     Document Type: Review

References (43)

1. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291: 1304-51
2. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921
3. McGuffin P, Riley B, Plomin R. Genomics and behavior. Toward behavioral genomics. Science 2001; 291: 1232-49
4. Moldin SO, Gottesman II. At issue: genes, experience, and chance in schizophrenia-positioning for the 21st century. Schizophr Bull 1997; 23: 547-61
5. Emahazion T, Feuk L, Jobs M et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 2001; 17: 407-13
6. Malhotra AK, Goldman D. Benefits and pitfalls encountered in psychiatric genetic association studies. Biol Psychiatry 1999; 45: 544-50
7. Glatt CE, Freimer NB. Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends Genet 2002; 18: 307-12
8. Vogel F, Schalt E, Kruger J, Propping P, Lehnert KF. The electroencephalogram (EEG) as a research tool in human behavior genetics: psychological examinations in healthy males with various inherited EEG variants. Hum Genet 1979; 47: 1-45
9. Axelrod BN. Are normative data from the 64-card version of the WCST comparable to the full WCST? Clin Neuropsychol 2002; 16: 7-11
10. Whalen PJ, Bush G, McNally RJ et al. The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry 1998; 44: 1219-28
11. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72
12. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3
13. Small GW, Mazziotta JC, Collins MT et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273: 942-7
14. Reiman EM, Caselli RJ, Yun LS et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-8
15. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091-5
16. Bookheimer SY, Strojwas MH, Cohen MS et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000; 343: 450-6
17. Rausch R, Babb TL. Hippocampal neuron loss and memory scores before and after temporal lobe surgery for epilepsy. Arch Neurol 1993; 50: 812-7
18. Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999; 39: 19-52
19. Lewis DA, Sesack SR, Levey AI, Rosenberg DR. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv Pharmacol 1998; 42: 703-6
20. Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 1996; 93: 13473-80
21. Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-22
22. Callicott JH, Mattay VS, Bertolino A et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999; 9: 20-6
23. Cohen JD, Perlstein WM, Braver TS et al. Temporal dynamics of brain activation during a working memory task. Nature 1997; 386: 604-8
24. Eberhard G, Ross S, Saaf J, Wahlund B, Wetterberg L. Psychoses in twins. A 10 year clinical and biochemical follow-up study. Schizophr Res 1989; 2: 367-74
25. Nurnberger Jr JI, Foroud T. Genetics of bipolar affective disorder. Curr Psychiatry Rep 2000; 2: 147-57
26. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31
27. Heinz A, Jones DW, Mazzanti C et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643-9
28. Little KY, McLaughlin DP, Zhang L et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155: 207-13
29. Melke J, Landen M, Baghei F et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet 2001; 105: 458-63
30. Du L, Bakish D, Hrdina PD. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet 2000; 10: 159-64
31. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 2001; 115: 358-64
32. Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998; 44: 179-92
33. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12 Suppl 1: 2-19
34. Ball D, Hill L, Freeman B et al. The serotonin transporter gene and peer-rated neuroticism. Neuroreport 1997; 8: 1301-4
35. Ebstein RP, Segman R, Benjamin J et al. 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet 1997; 74: 65-72
36. Katsuragi S, Kunugi H, Sano A et al. Association between serotonin transporter gene polymorphism and anxiety-related traits. Biol Psychiatry 1999; 45: 368-70
37. Flory JD, Manuck SB, Ferrell RE et al. Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 1999; 4: 93-6
38. Deary IJ, Battersby S, Whiteman MC et al. Neuroticism and polymorphisms in the serotonin transporter gene. Psychol Med 1999; 29: 735-9
39. Ohara K, Nagai M, Tsukamoto T, Tani K, Suzuki Y. Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders. Biol Psychiatry 1998; 44: 550-4
40. Hariri AR, Mattay VS, Tessitore A et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400-3
41. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002; 17: 317-23
42. Hariri AR, Mattay VS, Tessitore A et al. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 2002; 27: 1037-41
43. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry 2001; 6: 13-34